PE56396A1 - Proceso para purificar el antigeno de superficie de la hepatitis b viral que comprende al peptido pres2 - Google Patents
Proceso para purificar el antigeno de superficie de la hepatitis b viral que comprende al peptido pres2Info
- Publication number
- PE56396A1 PE56396A1 PE1995286655A PE28665595A PE56396A1 PE 56396 A1 PE56396 A1 PE 56396A1 PE 1995286655 A PE1995286655 A PE 1995286655A PE 28665595 A PE28665595 A PE 28665595A PE 56396 A1 PE56396 A1 PE 56396A1
- Authority
- PE
- Peru
- Prior art keywords
- surface antigen
- extract
- cell
- fraction
- silica
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 8
- 102000036639 antigens Human genes 0.000 title abstract 8
- 108091007433 antigens Proteins 0.000 title abstract 8
- 208000002672 hepatitis B Diseases 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 6
- 210000004027 cell Anatomy 0.000 abstract 4
- 239000000377 silicon dioxide Substances 0.000 abstract 3
- 238000004587 chromatography analysis Methods 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 238000005119 centrifugation Methods 0.000 abstract 1
- 238000002523 gelfiltration Methods 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 230000021962 pH elevation Effects 0.000 abstract 1
- 230000020477 pH reduction Effects 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19940033594 | 1994-12-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE56396A1 true PE56396A1 (es) | 1996-12-14 |
Family
ID=19400952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1995286655A PE56396A1 (es) | 1994-12-10 | 1995-12-07 | Proceso para purificar el antigeno de superficie de la hepatitis b viral que comprende al peptido pres2 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6362320B1 (enExample) |
| EP (1) | EP0716094B1 (enExample) |
| KR (1) | KR960023066A (enExample) |
| CN (1) | CN1057532C (enExample) |
| AR (1) | AR002006A1 (enExample) |
| AT (1) | ATE264341T1 (enExample) |
| BG (1) | BG63699B1 (enExample) |
| BR (1) | BR9505739A (enExample) |
| CA (1) | CA2164672C (enExample) |
| CO (1) | CO4480040A1 (enExample) |
| CZ (1) | CZ291024B6 (enExample) |
| DE (1) | DE69532878T2 (enExample) |
| DK (1) | DK0716094T3 (enExample) |
| ES (1) | ES2217272T3 (enExample) |
| JO (1) | JO1885B1 (enExample) |
| PE (1) | PE56396A1 (enExample) |
| PL (1) | PL182103B1 (enExample) |
| PT (1) | PT716094E (enExample) |
| RO (1) | RO113308B1 (enExample) |
| RU (1) | RU2122430C1 (enExample) |
| TR (1) | TR199501557A2 (enExample) |
| UY (1) | UY24112A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA79735C2 (uk) * | 2000-08-10 | 2007-07-25 | Глаксосмітклайн Байолоджікалз С.А. | Очищення антигенів вірусу гепатиту b (hbv) для використання у вакцинах |
| KR100405174B1 (ko) * | 2001-02-02 | 2003-11-12 | 씨제이 주식회사 | 재조합 β형 간염바이러스 표면항원의 정제방법 |
| RU2205023C1 (ru) * | 2002-05-14 | 2003-05-27 | Закрытое акционерное общество "Медицинские технологии - "МТХ" | Способ получения поверхностного антигена вируса гепатита в из рекомбинантных клеток дрожжей hansenula polymorpha и вакцина для иммунизации против гепатита в |
| ATE493659T1 (de) * | 2004-05-19 | 2011-01-15 | Advanced Life Science Inst Inc | Verfahren zum nachweis von hepatitis-b-virus |
| GB0522765D0 (en) * | 2005-11-08 | 2005-12-14 | Chiron Srl | Combination vaccine manufacture |
| RU2314125C1 (ru) * | 2006-04-25 | 2008-01-10 | Закрытое акционерное общество "Вектор-БиАльгам" | Способ получения инактивированной вакцины против вируса гепатита а |
| KR100948127B1 (ko) * | 2007-06-27 | 2010-03-18 | 주식회사 중앙백신연구소 | 복합호흡기 질환 돼지의 조직유제를 함유하는 백신 조성물 |
| MY178616A (en) | 2012-09-17 | 2020-10-19 | Grace W R & Co | Chromatography media and devices |
| FR2997222B1 (fr) * | 2012-10-19 | 2015-01-16 | Alstom Technology Ltd | Dispositif d'etablissement et/ou de coupure de courant a contacts permanents a usure reduite |
| CN107847907A (zh) | 2014-05-02 | 2018-03-27 | 格雷斯公司 | 官能化载体材料以及制备和使用官能化载体材料的方法 |
| BR112017026193B1 (pt) | 2015-06-05 | 2021-09-14 | W.R. Grace & Co-Conn | Adsorventes, método de produção dos adsorventes e uso dos adsorventes |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5340926A (en) * | 1983-03-25 | 1994-08-23 | Celltech, Limited | Process for the recovery of recombinantly produced protein from insoluble aggregate |
| US4649192A (en) * | 1985-05-30 | 1987-03-10 | Smith Kline-Rit | Method for the isolation and purification of hepatitis B surface antigen using polysorbate |
| US4816564A (en) * | 1986-01-31 | 1989-03-28 | Merck & Co., Inc. | Method for producing hepatitis B virus proteins in yeast |
| EP0291146B1 (en) * | 1987-03-09 | 1993-09-01 | Merck & Co. Inc. | Purification of recombinant hepatitis b surface antigen |
| EP0310178A1 (en) * | 1987-09-30 | 1989-04-05 | Merck & Co. Inc. | Recovery of pres2+S antigen |
| EP0314240A3 (en) * | 1987-10-26 | 1990-03-28 | Merck & Co. Inc. | Process for purifying recombinant hepatitis antigens |
| US5004688A (en) * | 1988-04-15 | 1991-04-02 | Phillips Petroleum Company | Purification of hepatitis proteins |
| US5030720A (en) * | 1988-09-01 | 1991-07-09 | Merck & Co., Inc. | Pres2+S hepatitis B vaccine derived from plasma |
| EP0384058A1 (en) * | 1989-02-09 | 1990-08-29 | Development Center For Biotechnology | Isolation of hepatitis B surface antigen from transformed yeast cells |
| CU22290A1 (es) * | 1990-10-08 | 1995-01-31 | Cigb | Procedimiento para la obtencion de antigeno de superficie del virus de la hepatitis b de superior capacidad inmunoganica y su uso en un preparado vacunal |
-
1995
- 1995-11-29 KR KR1019950044795A patent/KR960023066A/ko active Granted
- 1995-12-07 CA CA002164672A patent/CA2164672C/en not_active Expired - Fee Related
- 1995-12-07 PE PE1995286655A patent/PE56396A1/es not_active Application Discontinuation
- 1995-12-07 CO CO95057860A patent/CO4480040A1/es unknown
- 1995-12-07 JO JO19951885A patent/JO1885B1/en active
- 1995-12-08 AT AT95119383T patent/ATE264341T1/de not_active IP Right Cessation
- 1995-12-08 RO RO95-02141A patent/RO113308B1/ro unknown
- 1995-12-08 DE DE69532878T patent/DE69532878T2/de not_active Expired - Fee Related
- 1995-12-08 RU RU95120587A patent/RU2122430C1/ru not_active IP Right Cessation
- 1995-12-08 CZ CZ19953247A patent/CZ291024B6/cs not_active IP Right Cessation
- 1995-12-08 PT PT95119383T patent/PT716094E/pt unknown
- 1995-12-08 DK DK95119383T patent/DK0716094T3/da active
- 1995-12-08 PL PL95311735A patent/PL182103B1/pl not_active IP Right Cessation
- 1995-12-08 BG BG100212A patent/BG63699B1/bg unknown
- 1995-12-08 EP EP95119383A patent/EP0716094B1/en not_active Expired - Lifetime
- 1995-12-08 ES ES95119383T patent/ES2217272T3/es not_active Expired - Lifetime
- 1995-12-11 AR ARP950100498A patent/AR002006A1/es active IP Right Grant
- 1995-12-11 CN CN95120408A patent/CN1057532C/zh not_active Expired - Fee Related
- 1995-12-11 UY UY24112A patent/UY24112A1/es not_active IP Right Cessation
- 1995-12-11 BR BR9505739A patent/BR9505739A/pt not_active Application Discontinuation
- 1995-12-11 TR TR95/01557A patent/TR199501557A2/xx unknown
-
1999
- 1999-11-02 US US09/432,300 patent/US6362320B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2164672A1 (en) | 1996-06-11 |
| PL311735A1 (en) | 1996-06-24 |
| AR002006A1 (es) | 1998-01-07 |
| BR9505739A (pt) | 1997-12-23 |
| CZ291024B6 (cs) | 2002-12-11 |
| CO4480040A1 (es) | 1997-07-09 |
| RO113308B1 (ro) | 1998-06-30 |
| EP0716094A1 (en) | 1996-06-12 |
| DK0716094T3 (da) | 2004-07-26 |
| CN1057532C (zh) | 2000-10-18 |
| PT716094E (pt) | 2004-08-31 |
| ES2217272T3 (es) | 2004-11-01 |
| JO1885B1 (en) | 1997-12-15 |
| TR199501557A2 (tr) | 1997-03-21 |
| UY24112A1 (es) | 1996-05-10 |
| EP0716094B1 (en) | 2004-04-14 |
| ATE264341T1 (de) | 2004-04-15 |
| DE69532878T2 (de) | 2005-06-09 |
| CN1132211A (zh) | 1996-10-02 |
| BG100212A (bg) | 1996-12-31 |
| KR0177254B1 (enExample) | 1999-04-01 |
| CA2164672C (en) | 2004-06-22 |
| RU2122430C1 (ru) | 1998-11-27 |
| KR960023066A (ko) | 1996-07-18 |
| DE69532878D1 (de) | 2004-05-19 |
| US6362320B1 (en) | 2002-03-26 |
| PL182103B1 (pl) | 2001-11-30 |
| CZ324795A3 (en) | 1996-06-12 |
| BG63699B1 (bg) | 2002-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE56396A1 (es) | Proceso para purificar el antigeno de superficie de la hepatitis b viral que comprende al peptido pres2 | |
| KR860008276A (ko) | 단백질이 생성된 배양기로 부터 그것을 추출, 정제하는 방법 | |
| ES2139794T3 (es) | Purificacion de inhibidor de proteinasa alfa-1 usando nuevas condiciones de separacion cromatografica. | |
| Horvath et al. | Multifunctional apparatus for electrokinetic processing of proteins | |
| ATE122262T1 (de) | Multifunktionelle elektrische trennvorrichtung und trennverfahren. | |
| ES2076521T3 (es) | Procedimiento para la disociacion enzimatica de proteinas recombinantes mediando utilizacion de proteasa de iga. | |
| DK0652966T3 (da) | Fremgangsmåde til forøgelse af ekspression af virale proteiner | |
| ES2108681T3 (es) | Expresion de la albumina del suero humano en las levaduras metilotroficas. | |
| ES2139607T3 (es) | Anticuerpos monoclonales contra las proteinas e2/ns1 supuestas vhc y procedimientos de utilizacion de estos anticuerpos. | |
| ES2119821T3 (es) | Fraccion de calostro y su utilizacion como suplemento en los medios de cultivo celular. | |
| DK562189A (da) | Fremgangsmaade til isolering af biologisk aktive forbindelser | |
| ES2070855T3 (es) | Metodo para purificar una proteina. | |
| DK0646594T3 (da) | Fremgangsmåde til rensning af proteiner | |
| Hardwicke et al. | Human α1-glycoproteins Separation from pathological urine and examination by immunological and electrophoretic methods | |
| ATE162310T1 (de) | Nachweis von heparinbindenden seminalproteinen | |
| DK100888D0 (da) | Fremgangsmaade til at rense rekombinant pres-1/s-2/s hepatitis b antigen fra gaer | |
| ES2009587A6 (es) | Un metodo para purificar un polipeptido. | |
| Murphy et al. | Physical Heterogeneity of Bovine Gamma Globulins: Gamma-1M Globulin Electrophoretic Heterogeneity. | |
| ES2041690T3 (es) | Metodo para la purificacion de anticuerpos. | |
| RU96124514A (ru) | Способ выделения ангиогенина | |
| Colle et al. | The use of preparative continuous flow electrophoresis to study low molecular weight proteins in urine | |
| ATE110853T1 (de) | Immuntestverfahren für zelluläres eiweiss. | |
| KR930013105A (ko) | 양 성장 호르몬의 정제 방법 | |
| KR970073604A (ko) | 재조합 b형 간염 표면 항원의 정제방법 | |
| KR910016926A (ko) | 인간 β-인터페론의 정제방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |